Skip to main content
. 2021 Jun 18;2021:8848227. doi: 10.1155/2021/8848227

Table 2.

Results of Cox analysis of the risk model and clinical data.

Cox ID B SE z HR HR.95L HR.95H p value
UniCox Gender -0.03 0.16 -0.18 0.97 0.72 1.32 8.61E − 01
Stage 0.35 0.09 4.03 1.42 1.20 1.68 5.52E − 05
T 0.34 0.07 5.02 1.41 1.23 1.62 5.20E − 07
M 0.72 0.33 2.20 2.05 1.08 3.90 2.80E − 02
N 0.28 0.07 4.34 1.33 1.17 1.51 1.39E − 05
Risk score 0.66 0.07 8.84 1.94 1.67 2.25 9.74E − 19

MultiCox Gender 0.03 0.16 0.17 1.03 0.76 1.39 8.68E − 01
Stage 0.08 0.12 0.67 1.09 0.85 1.38 5.03E − 01
T 0.24 0.07 3.37 1.27 1.11 1.46 7.46E − 04
M 0.49 0.38 1.29 1.63 0.78 3.43 1.96E − 01
N 0.21 0.08 2.66 1.23 1.06 1.43 7.78E − 03
Risk score 0.59 0.08 7.55 1.81 1.55 2.11 4.21E − 14